Akebia Therapeutics (AKBA) Gross Margin Growth (1y) (2019 - 2026)
Akebia Therapeutics (AKBA) Gross Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 128.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -22.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -503.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -543.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -271.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -9.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -8.00 |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | -965.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -965.00 |
| Dec 31, 2025 | 267.00 |
| Sep 30, 2025 | -221.00 |
| Jun 30, 2025 | 2,318.00 |
| Mar 31, 2025 | 2,229.00 |
| Dec 31, 2024 | -724.00 |
| Sep 30, 2024 | 2,907.00 |
| Jun 30, 2024 | -840.00 |
| Mar 31, 2024 | -765.00 |
| Dec 31, 2023 | 2,513.00 |
| Sep 30, 2023 | 3,575.00 |
| Jun 30, 2023 | -1,594.00 |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | -4,993.00 |
| Sep 30, 2022 | -6,436.00 |
| Jun 30, 2022 | 6,746.00 |
| Mar 31, 2022 | -3.04 Mn |
| Dec 31, 2021 | 29,381.00 |
| Sep 30, 2021 | 18,808.00 |
| Jun 30, 2021 | 11,153.00 |